GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltagen Inc (OTCPK:DGEN) » Definitions » ROCE %

Deltagen (Deltagen) ROCE % : -12.86% (As of Jun. 2007)


View and export this data going back to 2000. Start your Free Trial

What is Deltagen ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Deltagen's annualized ROCE % for the quarter that ended in Jun. 2007 was -12.86%.


Deltagen ROCE % Historical Data

The historical data trend for Deltagen's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltagen ROCE % Chart

Deltagen Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec05 Dec06
ROCE %
Get a 7-Day Free Trial -53.65 -46.27 -164.60 -1.87 42.69

Deltagen Quarterly Data
Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.70 3.92 57.94 -45.28 -12.86

Deltagen ROCE % Calculation

Deltagen's annualized ROCE % for the fiscal year that ended in Dec. 2006 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2006 )  (A: Dec. 2005 )(A: Dec. 2006 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2006 )  (A: Dec. 2005 )(A: Dec. 2006 )
=3.955/( ( (15.735 - 6.035) + (9.667 - 0.84) )/ 2 )
=3.955/( (9.7+8.827)/ 2 )
=3.955/9.2635
=42.69 %

Deltagen's ROCE % of for the quarter that ended in Jun. 2007 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2007 )  (Q: Mar. 2007 )(Q: Jun. 2007 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2007 )  (Q: Mar. 2007 )(Q: Jun. 2007 )
=-0.928/( ( (8.702 - 0.445) + (6.666 - 0.49) )/ 2 )
=-0.928/( ( 8.257 + 6.176 )/ 2 )
=-0.928/7.2165
=-12.86 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2007) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltagen  (OTCPK:DGEN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Deltagen ROCE % Related Terms

Thank you for viewing the detailed overview of Deltagen's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltagen (Deltagen) Business Description

Traded in Other Exchanges
N/A
Address
1900 S. Norfolk Street, Suite 105, San Mateo, CA, USA, 94403
Deltagen Inc is a provider of drug discovery tools and services to the biopharmaceutical industry.

Deltagen (Deltagen) Headlines

No Headlines